41345-36-2

Basic information

• Product Name: Sodium 2-chlorobenzylsulphonate
• Synonyms: Sodium 2-chlorobenzylsulphonate
• CAS NO: 41345-36-2
• Molecular Weight: 228.632
• Mol File: 41345-36-2.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Sodium 2-chlorobenzylsulphonate(CAS DataBase Reference)
• NIST Chemistry Reference: Sodium 2-chlorobenzylsulphonate(41345-36-2)
• EPA Substance Registry System: Sodium 2-chlorobenzylsulphonate(41345-36-2)

Safety Data

• Hazardous Substances Data: 41345-36-2(Hazardous Substances Data)

Upstream product

• 611-19-8 1-chloro-2-(chloromethyl)benzene 

Downstream Products

• 89665-79-2 (2-chlorophenyl)-methanesulfonamide 
• 110654-49-4 1,3,5-Tris-(2-chloro-phenylmethanesulfonyl)-[1,3,5]triazinane 
• 1417156-37-6 1-(2-chlorophenyl)-3-phenyl-2-thia-3-azabicyclo[3.1.0]hexane 2,2-dioxide 
• 1417156-41-2 1-(2-chlorophenyl)-3-(4-methoxyphenyl)-2-thia-3-azabicyclo[3.1.0]hexane 2,2-dioxide 
• 1417156-46-7 N-(but-3-enyl)-1-(2-chlorophenyl)-N-phenylmethanesulfonamide 
• 1417156-47-8 N-(4-bromophenyl)-1-(2-chlorophenyl)-N-(3,4-dibromobutyl)methanesulfonamide 
• 1417156-48-9 N-(4-bromophenyl)-N-(but-3-ynyl)-1-(2-chlorophenyl)methanesulfonamide 
• 1417156-54-7 1-(2-chlorophenyl)-2-thia-3-azabicyclo[3.1.0]hexane 2,2-dioxide 
• 85952-18-7 1-(2-chlorophenyl)-N-phenylmethanesulfonamide 
• 662144-73-2 1-(2-chlorophenyl)-N-(4-methoxyphenyl)methanesulfonamide 
• 1417156-13-8 5-(2-chlorophenyl)-2-phenylisothiazolidine 1,1-dioxide 
• 1417156-23-0 N-allyl-1-(2-chlorophenyl)-N-phenylmethanesulfonamide 
• 1417156-27-4 N-allyl-1-(2-chlorophenyl)-N-(4-methoxyphenyl)methanesulfonamide 
• 77421-13-7 (2-chlorobenzyl)sulfonyl chloride 

Relevant articles and documents

Preparation of sodium sulfonates using by copper as catalyst

The sodium alkyl sulfonates were prepared by Strecker reaction. The synthesis of sodium chloroethyl sulfonate from dichloroethane and sodium sulfite with different catalysts, it was found that copper was an efficient catalyst with a yield (81%). The reaction conditions were also optimized to make the route more competitive and suitable for large-scale industrial production. Besides, some more sulfonates were also obtained with copper as catalyst via Strecker reaction.

N-1H-Benzimidazol-5-ylbenzenesulfonamide derivatives as potent hPXR agonists

The Human Pregnane X Receptor (hPXR) is a nuclear receptor that regulates the expression of phase I and phase II drug-metabolizing enzymes, as well as that of drug transporters. Because this receptor plays a critical role in protecting tissues from potentially toxic endo- and xenobiotics, highly active agonists could represent novel therapeutic tools in treating several human diseases. Using an in vitro screening reporter system that allow to characterize hPXR activators and a first step of chemical modifications of an original agonist ligand (C2BA-4, 1-(2-chlorophenyl)-N-[1-(1-phenylethyl)-1H-benzimidazol-5-yl]methanesulf onamide), we identified compounds with a N-1H-benzimidazol-5-ylbenzenesulfonamide scaffold as a potent family of hPXR agonists. Further chemical modifications allowed us to identify enhanced activators, notably N-(1-benzyl-1H-benzimidazol-5-yl)-2,3,4,5,6-pentamethylbenzenesulfonamid e (6n) with an EC50 value in the subnanomolar range. Accordingly to their potent EC50, these compounds induced an efficient protection of hPXR against proteolytic digestion by trypsin even at very low ligand concentrations and were able to induce the expression of the main target genes of hPXR, CYP3A4 and CYP2B6, in primary cultures of human hepatocytes.